DB 06/19 - OpenAI Adds Enterprise Cost Controls as Health AI Gains Real Diagnostic Power
OpenAI rolled out spend management tools for enterprise customers while demonstrating its AI models diagnosing rare diseases physicians had missed for years—marking a shift from general chatbot use to specialized medical applications. Meanwhile, competition is intensifying as ChatGPT's market share faces pressure from rivals.
Read full analysis →